William Rice
Vorstandsvorsitzender bei APTOSE BIOSCIENCES INC.
Vermögen: 39 691 $ am 30.04.2024
Aktive Positionen von William Rice
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| APTOSE BIOSCIENCES INC. | Comptroller/Controller/Auditor | 07.04.2022 | - |
| Vorstandsvorsitzender | 28.10.2013 | - | |
| Vorsitzender | 28.10.2013 | - | |
| Präsident | 28.10.2013 | - | |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Vorsitzender | 28.09.2010 | - |
| Direktor/Vorstandsmitglied | 28.09.2010 | - | |
| Vorstandsvorsitzender | 01.01.2003 | - | |
| Präsident | 01.01.2003 | - |
Karriereverlauf von William Rice
Ehemalige bekannte Positionen von William Rice
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC. | Direktor/Vorstandsmitglied | 08.06.2015 | 01.01.2021 |
| Independent Dir/Board Member | 08.06.2015 | 01.01.2021 | |
| ACHILLION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 17.08.1998 | 01.08.2003 |
| Vorstandsvorsitzender | 17.08.1998 | 01.08.2003 | |
| Gründer | 17.08.1998 | 01.08.2003 | |
| Präsident | 17.08.1998 | 01.08.2003 | |
| Frederick National Laboratory For Cancer Research | Corporate Officer/Principal | 01.01.1992 | 01.01.1998 |
| Emory University School of Medicine | Corporate Officer/Principal | 01.01.1989 | 01.01.1992 |
Ausbildung von William Rice
| Emory University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Kanada | 3 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| President | 3 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
| Frederick National Laboratory For Cancer Research |
- Börse
- Insiders
- William Rice
- Erfahrung
